Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027651 (
tumor
)
685,946
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A patient with typical clinical and biochemical features of a glucagonoma also presented obvious signs of hypokalemia, indicating combined secretion of
renin
by the
tumor
. The latter was voluminous, was located in the tail of the pancreas and was of a malignant nature as shown by the development of secondary hepatic metastases. Syndromes associated with glucagonoma and mixed or combined insular tumors are reviewed in detail.
...
PMID:[The glucagonoma syndrome. Review of the literature. Apropos of a case]. 287 45
200 patients with mineralocorticoid hypertension were studied at the Clinical Study Center. The study of 150 patients with primary aldosteronism revealed five distinct subsets based on their responses to the upright posture, after administration of intravenous saline, deoxycorticosterone acetate, and spironolactone. Two new types were identified--aldosterone producing responsive adenoma (AP-RA) and primary adrenal hyperplasia (PAH). Patients with AP-RA maintained normal physiologic responses to the above maneuvers. Patients with PAH had responses similar to patients with an aldosterone producing adenoma (APA) but no
tumor
was identified. Both types were cured by unilateral adrenalectomy. There has been no change in subtype in up to 20 years of follow-up. The notion of a continuum from low
renin
hypertension to APA is not supported. Primary deoxycorticosteronism caused by a benign adrenal adenoma, malignancy and hyperplasia is described. Uniquely, overproduction of the 17-deoxysteroids of the zona fasciculata occurs with normal 17-hydroxy function. After the removal of a benign adenoma the contralateral adrenal gland revealed a delay in the 17-deoxysteroid responses to ACTH in the face of normal cortisol increases. This suggests that an independent pituitary regulator of the 17-deoxypathway may exist. Other hypertensive disorders with excessive deoxycorticosterone production are linked with increases of ACTH and cortisol levels. The hallmarks of primary deoxycorticosteronism are hypertension with hypokalemia, suppression of
renin
and aldosterone, and overproduction of the 17-deoxysteroids.
...
PMID:Identification and implications of new types of mineralocorticoid hypertension. 291 10
The changes in active and inactive
renin
after captopril (n = 29) or furosemide administration (n = 10) were studied in hypertensive patients. Furthermore, after percutaneous transluminal angioplasty (PTA) in 3 cases of renovascular hypertension (RVH), and after nephrectomy in a case of juxtaglomerular cell
tumor
, the time course of the changes in these two types of
renin
was investigated. Inactive
renin
was activated by trypsin treatment. Plasma
renin
concentration was measured by using an excess of sheep substrate. In patients with essential hypertension or primary aldosteronism, inactive
renin
was unchanged, irrespective of response in active
renin
, after the administration of captopril and furosemide. In patients with RVH, inactive
renin
was markedly decreased by furosemide but unchanged by captopril, in spite of significant increase in active
renin
. After PTA and nephrectomy, inactive
renin
decreased slower than active
renin
. These data support the idea that in patients with RVH, the increase in active
renin
by furosemide is at least partly due to the activation of inactive
renin
. It is also suggested that the increase in active
renin
by captopril is mainly due to the promoted release of active
renin
from the kidney. Furthermore, it seems likely that the metabolic clearance of inactive
renin
is slower than that in active
renin
.
...
PMID:The changes in active and inactive renin induced by various maneuvers in hypertensive patients. 294 48
Left ventricular hypertrophy is a complex cellular response to a variety of pathologic states. In recent years it has become clear that a variety of hormones are present in the heart and may participate in the genesis of left ventricular hypertrophy. Our group has demonstrated the synthesis of
renin
by cultured canine arterial smooth muscle cells and has recently demonstrated the presence of
renin
and angiotensin II in myocardial cell preparations. Angiotensin II concentration was (+/- standard error of the mean) 4.19 +/- 1.52 pg/10(6) cells. Evidence has been developed to suggest that these components of the
renin
-angiotensin system are modulatable. These data, taken together with studies from our laboratory and others, raise the distinct possibility that components of the
renin
-angiotensin system together with catecholamines play a role in the genesis of left ventricular hypertrophy. Recent evidence suggests that the myc proto-oncogene is activated in cells undergoing catecholamine-induced hypertrophy and our laboratory has detected activation of the sis proto-oncogene in at least 1 model of left ventricular hypertrophy. These findings raise the possibility that similar pathogenetic cellular mechanisms operate to produce myocardial hypertrophy, vascular hyperplasia and hypertrophy, and some forms of benign
neoplasia
. The possible significance of these findings and their relation to peptide hormones and growth factors are discussed.
...
PMID:Cellular mechanisms of growth in cardiovascular tissue. 296 Dec 44
A 26-year-old man with hypothalamic hypodipsia-hypernatremia syndrome is reported, who presented with adipsia, hypernatremia, and impaired osmolality-mediated arginine vassopressin (AVP) secretion. A chorionic gonadotropin-secreting
tumor
was detected in the anterior hypothalamus and treated with external irradiation. After the treatment, hypernatremia persisted and was not corrected by fluid loading, osmolality-mediated AVP secretion remained impaired. Despite the absence of signs of hydropenia, hypovolemia was suggested by low blood pressure and elevated plasma indices of the
renin
-angiotensin system, and supported by blood volume determination. The plasma aldosterone concentrations were inappropriately low for the
renin
-angiotensin status. The plasma atrial natriuretic polypeptide (ANP) level was normal in spite of hypovolemia and increased more than double after fluid loading. Hypernatremia, primarily caused by hypodipsia and impaired osmolality-mediated AVP secretion, secondarily sustained ANP secretion and suppressed aldosterone release, which conceivably contributed to the development and perpetuation of hypovolemia in this patient.
...
PMID:Pathogenesis of extracellular fluid abnormalities of hypothalamic hypodipsia-hypernatremia syndrome. 297 77
A human juxtaglomerular cell (JGC)
tumor
was used for the immortalization of
renin
-secreting cells. The transfection of primary JGC with three different simian virus 40 (SV40) mutants resulted in the continuous production of
renin
-secreting cells. The most efficient
renin
-producing cells (producing about 400 pg of
renin
per 24 hr per ml of culture medium) were those transfected with the PAS SV40 mutant. The
renin
production was stable and the cell cultures have been maintained for greater than 1 year. Two types of cells were cultured together and could not be separated: round and birefringent cells, which exhibited features of mast cells, and elongated cells containing myofilaments and secretory granules. Immunocytochemical staining showed the presence of
renin
in this latter cell type. The
renin
produced by the transfected cells was not stored within the cells but was released rapidly into the medium. More than 95% of the
renin
produced was prorenin, which, after activation, had characteristics similar to those of pure human standard
renin
as to its enzymatic, immunologic, and biochemical properties, except that it was less glycosylated. These stable JGC tumoral cell lines provide a unique system for studying human
renin
biosynthesis and its regulation in vitro.
...
PMID:Isolation of renin-producing human cells by transfection with three simian virus 40 mutants. 300 6
A 56-year-old woman presented with intracranial hemorrhage. Laboratory examinations revealed severe hypertension, hypokalemia, elevated aldosterone excretion, and suppressed plasma
renin
activity. Left adrenocortical
tumor
was suspected and adrenalectomy was performed. The laboratory data after operation, however, showed no significant difference from the preoperative data. On the basis of further examinations, dexamethasone was administered and returned blood pressure to normal, and also normalized serum potassium, plasma aldosterone, and
renin
activity. The patient's illness was diagnosed as glucocorticoid-suppressible hyperaldosteronism. Light microscopically, the zona glomerulosa was hypertrophic and the outer zona fasciculata decreased in lipid droplets and was centrifugally arranged in small alveoli. Electronmicroscopically, the cells of the outer zona fasciculata had several lipid droplets and well-developed sER. Mitochondria were round to oval with lamellar or lamellovesicular cristae. These findings were evidence of hyperfunction. The cytoplasm of the cells also contained spironolactone bodies. Therefore, it is assumed that the aldosterone, which induced the disorder, was produced mainly in the outer zona fasciculata.
...
PMID:Glucocorticoid-suppressible hyperaldosteronism. Ultrastructural observation of a case. 300 3
Congestive heart failure is an unusual complication of the hyperreninemia of Wilms' tumors. Cases with bilateral tumors present a difficult management problem. This is a report of the successful medical management of a child with congestive heart failure secondary to hyperreninemia from bilateral Wilms' tumor. Hypertension and hyperreninemia were extensively documented. Their etiologic relation to the congestive heart failure was supported by the patient's improved cardiac function following specific
renin
-angiotensin blockade. With unilateral tumors, surgical excision corrects the hypertension; however, with large bilateral tumors, excision is out of the question. A unique feature of this case is the ability to control the blood pressure with saralasin. With subsequent antitumor therapy,
renin
concentrations decreased proportional to
tumor
size, and
renin
angiotensin blocking therapy could be discontinued.
...
PMID:Congestive heart failure, hypertension, and hyperreninemia in bilateral Wilms' tumor: successful medical management. 300 17
Immunoperoxidase staining for
renin
was performed with renal tumors, including juxtaglomerular (JG) tumor, Wilms' tumors, renal adenocarcinomas, renal oncocytomas, and cortical adenomas. Compared with the JG apparatus adjacent to the glomerulus, JG
tumor
cells were less darkly but diffusely stained for
renin
. One of five Wilms' tumors revealed more numerous
renin
-containing
tumor
cells than the adjacent renal cortex, whereas three of ten renal adenocarcinomas and two of three renal oncocytomas revealed only focally
renin
-positive
tumor
cell cytoplasms. None of six cortical adenomas were positive for
renin
. With available fresh
tumor
tissue,
renin
activity was studied by measuring newly formed angiotensin I by radioimmunoassay. JG
tumor
contained markedly elevated
renin
activity, whereas one Wilms' tumor and two renal adenocarcinomas contained no more than 2% of
renin
activity of the renal cortex, more than 50% of which was inactive
renin
. These findings suggest that the JG
tumor
elaborates enormous amounts of active
renin
, whereas other renal tumors produce lesser amounts of
renin
, more than half of which is inactive
renin
.
...
PMID:Immunohistochemical localization of renin in renal tumors. 302 44
Renin-containing cells have been identified in nephroblastoma. A prospective study of eight children with nephroblastoma has demonstrated abnormally high levels of total
renin
. The increase in total
renin
was due to increased levels of inactive
renin
(prorenin), rather than the active
renin
. These high levels decreased to normal after operation. The plasma level of inactive
renin
could be a useful biochemical
tumor
marker in nephroblastoma.
...
PMID:Inactive renin: a tumor marker in nephroblastoma. 303 Dec 61
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>